IL1F10 and colorectal carcinoma: Hence, it is reasonable to infer that our current finding, indicating a better prognosis for CRC patients with IL-38hi and PD-1low expression compared to those with IL-38low and PD-1hi expression, further underscores the crucial protective role of IL-38 in CRC development.